Category Specific RSS

parkinsons

First patients dosed in Phase 2 clinical trials to tackle Parkinson’s disease

Parkinson’s UK, in collaboration with Australian researchers, has taken a major step towards preventing the development of Parkinson’s disease with…

2 years ago

Opening a new frontier in treating Parkinson’s disease

More than 100,000 people in Australia live with Parkinson’s—a central nervous system disorder affecting one’s movement and mood. It is…

3 years ago

Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial

This morning’s announcement may have surprised many investors following the Pharmaxis (ASX: PXS) story because where on earth does Parkinson’s…

3 years ago

Alterity Therapeutics moves neuroprotective drug to Phase 2 trials

Seven to ten years. That’s how long someone diagnosed with multiple system atrophy (MSA) has to live from when symptoms…

3 years ago